Volume 29, Number 5—May 2023
Dispatch
Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern
Table
SARS-CoV-2 isolate | WHO label | PANGO label | GISAID/GenBank accession no. | Aerosol half-life, h | Surface half-life, h |
---|---|---|---|---|---|
hu/USA/CA_CDC_5574/2020 | A | MN985325.1 | 3.2 9 (2.33–4.98) | 4.82 (4.23–5.49) | |
hCoV-19/USA/MT-RML-7/2020 | B.1 | MW127503.1 | 3.99 (2.73–7.2) | 5.16 (4.48–5.96) | |
hCoV-19/England/204820464/2020 | Alpha | B.1.1.7 | EPI_ISL_683466 | 6.13 (3.14–27.5) | 5.13 (4.59–5.74) |
hCoV-19/USA/MD-HP01542/2021 | Beta | B.1.351 | EPI_ISL_890360 | 5.13 (3.16–12.3) | 5.73 (5.01–6.72) |
hCoV-19/USA/KY-CDC-2-4242084/2021 | Delta | B.1.617.2 | EPI_ISL_1823618 | 3.12 (2.29–4.73) | 4.38 (3.48–5.65) |
hCoV-19/USA/WI-WSLH-221686/2021 | Omicron | B.1.1.529 | EPI_ISL_7263803 | 2.15 (1.35–4.04) | 3.58 (2.88–4.47) |
*The half-life of the aerosols or on surface is presented as posterior median value with posterior quantiles. WHO, World Health Organization.
1These authors contributed equally to this article.
2Current affiliation: Lovelace Biomedical Research Institute, Albuquerque, New Mexico, USA.
Page created: March 02, 2023
Page updated: April 19, 2023
Page reviewed: April 19, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.